Print this page

2022 Werfen and AFMS Partnership meeting

Werfen and AFMS organized the first Partnership meeting held from March 22nd to March 24th in Dubai, UAE.

The cooperation between Werfen and its local KSA partner, AFMS, is unique.

Our partnership started in 2008 with the acquisition of INOVA and it strengthened in 2015 once Instrumentation Laboratory distribution rights were consolidated under AFMS company.

Another great milestone was achieved in 2021, when Werfen strategically decided to consolidate all the Werfen IVD products under AFMS, announcing a long-term partnership between Werfen and AFMS in KSA.

Apart of meeting together to celebrate so many years of relationship, great achievements and amazing relationship, the agenda was designed to align priorities and strategies for the future of the business in KSA.

More than 30 AFMS employees involved in the Werfen business attended the 2022 Werfen and AFMS Partnership Meeting. Among the attendants we proudly counted Mr. Hussein Fares, Abdulla Fouad Group CEO, Mr. Asem Manasra, AFMS General Manager and Mr. Pepe Zamora, Werfen VP EEMEA.

The great networking and cooperation environment was perfect to review the history of our partnership, the future key moves and confirming key targets to achieve our strategic plan 2025: contribute to improve the best-in-class patient care solutions, becoming and securing the leadership for Werfen specialized disciplines Haemostasis, Acute Care Diagnostics and Autoimmunity business lines in the Kingdom of Saudi Arabia.

Oscar Marquez, Country Manager ME

Last modified on Thursday, 09 June 2022 08:04